 |
市場調查報告書
商品編碼
1935206
念珠菌症市場按藥物類別、類型、給藥途徑、通路和地區分類Candidiasis Market, By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
據估計，念珠菌症市場在 2026 年的價值為 13.072 億美元，預計到 2033 年將達到 17.907 億美元，2026 年至 2033 年的複合年成長率為 4.6%。
| 報告覆蓋範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 13.072億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 預測期（2026-2033年）複合年成長率： | 4.60% | 2033 年的預測值： | 17.907億美元 |
念珠菌症的治療治療方法多種多樣，包括口服藥物、注射劑和藥膏。通常使用非處方或處方箋抗真菌藥物進行治療。消費者對念珠菌症的認知不斷提高以及治療方法方案的日益增多是推動念珠菌症市場成長的主要因素。
市場動態
由於針對由白色念珠菌引起的侵襲性真菌感染疾病的頻譜抗真菌藥物的持續研發，全球念珠菌症市場預計將顯著成長。例如，2018年10月，美國微生物學會的研究人員發現了一種名為鹽酸阿來昔定的化合物，該化合物對多種真菌病原體表現出優異的抗真菌和抗生物膜活性，被認為具有作為通用抗真菌藥物的巨大潛力。
然而，非處方藥等替代治療方法的普及預計將阻礙市場成長。
本次調查的主要特點
- 本報告以 2025 年為基準年，對全球念珠菌症市場進行了詳細分析，並給出了預測期（2026-2033 年）內的市場規模和復合年成長率（%）。
- 它還重點介紹了各個細分市場的潛在商機，並解釋了該市場具有吸引力的投資提案矩陣。
- 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 該報告根據以下參數對全球念珠菌症市場的主要參與者進行了分析：公司概況、財務業績、產品系列、市場地位、分銷策略、關鍵發展、戰略和未來計劃。
- 本報告的研究結果將幫助負責人和經營團隊就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
- 這份全球念珠菌症市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過全球念珠菌症市場分析中使用的各種策略矩陣輕鬆做出決策。
目錄
第1章 研究目標與前提條件
- 調查目的
- 先決條件
- 簡稱
第2章 市場範圍
- 報告概述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、監管與趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 市場機遇
- 影響分析
- 藥物依從性和轉換（美國）
- 市場趨勢
- 管道分析
- 重大進展
- 監管情景
- 救贖方案
- 併購趨勢
- PEST分析
- 流行病學
4. 2026-2033年全球念珠菌症治療藥物市場（依藥物類別分類）
- Azole
- Echinocandins
- Polyenes
- Flucytosine
5. 2026-2033年全球念珠菌症治療市場（依類型分類）
- 口腔、咽喉及食道念珠菌感染疾病
- 陰道念珠菌症
- 侵襲性/全身性念珠菌症
6. 2026-2033年全球念珠菌症市場依給藥途徑分類
- 口服
- 腸外
- 外用
7. 2026-2033年全球念珠菌症市場依通路分類
- 醫院藥房
- 零售藥房
- 網路藥房
8. 2026-2033年全球念珠菌症治療市場（按地區分類）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 南非
- 中非
- 北非
第9章 競爭情勢
- 熱圖分析
- 市佔率分析
- Basilea Pharmaceutica Ltd.
- Astellas Pharma Inc.
- Grupo Ferrer Internacional, SA
- Pacgen Life Science Corporation
- NovaDigm Therapeutics, Inc.
- Cidara Therapeutics, Inc.
- Amplyx Pharmaceuticals Inc.
- Pfizer, Inc.
第10章各節
- 參考
- 調查方法
簡介目錄
Product Code: CMI229
Candidiasis Market is estimated to be valued at USD 1,307.2 Mn in 2026 and is expected to reach USD 1,790.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,307.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.60% | 2033 Value Projection: | USD 1,790.7 Mn |
Candidiasis is treated using various treatment options such as oral medication, injection, and ointments. The condition is usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines. Increasing consumer awareness about candidiasis and growing number of treatment options are major factors that are fueling growth of the candidiasis market.
Market Dynamics
The global candidiasis market is expected to witness significant growth, owing to increasing research for development of novel medications showcasing broad-spectrum antifungal activity against invasive fungal infections caused due to Candida albicans. For instance, in October 2018, researchers at the American Society for Microbiology identified a compound alexidine dihydrochloride, which has the highest antifungal and anti-biofilm activity against a diverse range of fungal pathogens, thus having a greater potential for use as a pan-antifungal drug.
However, easy access to alternative treatment methods such as over-the-counter treatments and others are expected to hinder the market growth.
Key features of the study
- This report provides in-depth analysis of the global candidiasis market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global candidiasis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., and Pfizer, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global candidiasis market
Market Segmentation
- By Drug Class
- Azoles
- Echinocandins
- Polyenes
- Flucytosine
- By Type
- Candida infections of the mouth, throat, and esophagus
- Vaginal candidiasis
- Invasive/Systemic candidiasis
- By Route of Administration
- Oral
- Parenteral
- Topical
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Basilea Pharmaceutica Ltd.
- Astellas Pharma Inc.
- Grupo Ferrer Internacional, S.A.
- Pacgen Life Science Corporation
- NovaDigm Therapeutics, Inc.
- Cidara Therapeutics, Inc.
- Amplyx Pharmaceuticals Inc.
- Pfizer, Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Adherence and Switch (U.S.)
- Market Trends
- Pipeline Analysis
- Key Developments
- Regulatory Scenario
- Reimbursement Scenario
- Merger and Acquisition Scenario
- PEST Analysis
- Epidemiology
4. Global Candidiasis Market, By Drug Class, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Flucytosine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Candidiasis Market, By Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Candida infections of the mouth, throat, and esophagus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Vaginal candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Invasive/Systemic candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Candidiasis Market, By Route of Administration, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Candidiasis Market, By Distribution Channel, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
8. Global Candidiasis Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- North America
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Basilea Pharmaceutica Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Grupo Ferrer Internacional, S.A.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pacgen Life Science Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NovaDigm Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cidara Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amplyx Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Basilea Pharmaceutica Ltd.
10. Section
- References
- Research Methodology
- About Us and Sales Contact
